Comparison of the exon skipping efficacy of different chemically modified antisense oligonucleotides within the mouse retina

被引：0
|
作者：
Vazquez-Dominguez, I. [1 ,2 ]
Allo-Anido, A. [1 ]
Duijkers, L. [1 ]
Hoppenbrouwers, T. [1 ,2 ]
Hoogendoorn, A. [1 ]
Collin, R. W. J. [1 ,2 ]
Garanto, A. [1 ,3 ,4 ]
机构：
[1] Radboud Univ Nijmegen Med Ctr, Dept Human Genet, Nijmegen, Netherlands
[2] Radboud Univ Nijmegen Med Ctr, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands
[3] Radboud Univ Nijmegen Med Ctr, Dept Pediat, Amalia Childrens Hosp, Dept Human Genet, Nijmegen, Netherlands
[4] Radboud Univ Nijmegen Med Ctr, Radboud Inst Mol Life Sci RIMLS, Nijmegen, Netherlands
来源：
HUMAN GENE THERAPY | 2021年 / 32卷 / 19-20期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P338
引用
收藏
页码：A132 / A132
页数：1
相关论文
共 50 条
  • [1] Efficacy, biodistribution and safety comparison of chemically modified antisense oligonucleotides in the retina
    Garanto, Alex
    Anido, Alejandro Allo
    Duijkers, Lonneke
    Hoppenbrouwers, Tamara
    Hoogendoorn, Anita
    Collin, Rob
    Dominguez, Irene Vazquez
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [2] Efficacy, biodistribution and safety comparison of chemically modified antisense oligonucleotides in the retina
    Vazquez-Dominguez, Irene
    Anido, Alejandro Allo
    Duijkers, Lonneke
    Hoppenbrouwers, Tamara
    Hoogendoorn, Anita D. M.
    Koster, Celine
    Collin, Rob W. J.
    Garanto, Alejandro
    NUCLEIC ACIDS RESEARCH, 2024, 52 (17) : 10447 - 10463
  • [3] EVALUATION OF EXON SKIPPING USING NOVEL CHEMICALLY-MODIFIED ANTISENSE OLIGONUCLEOTIDES
    Veedu, Rakesh N.
    JOURNAL OF GENE MEDICINE, 2018, 20 (01):
  • [4] Morpholino antisense oligonucleotides for inducing exon skipping
    Fletcher, S
    Gebski, BL
    Mann, CJ
    Wilton, SD
    NEUROMUSCULAR DISORDERS, 2003, 13 (7-8) : 632 - 632
  • [5] Morpholino antisense oligonucleotides for inducing exon skipping
    Gebski, BL
    Mann, CJ
    Fletcher, S
    Wilton, SD
    JOURNAL OF GENE MEDICINE, 2003, 5 (05): : S10 - S10
  • [6] Wild-Type Mouse Models to Screen Antisense Oligonucleotides for Exon-Skipping Efficacy in Duchenne Muscular Dystrophy
    Cao, Limin
    Han, Gang
    Gu, Ben
    Yin, HaiFang
    PLOS ONE, 2014, 9 (11):
  • [7] Design of antisense Oligonucleotides for Exon skipping of the human dystrophin gene
    Popplewell, L. J.
    Dickson, G.
    Graham, I. R.
    HUMAN GENE THERAPY, 2008, 19 (04) : 407 - 407
  • [8] Exon-skipping antisense oligonucleotides for cystic fibrosis therapy
    Kim, Young Jin
    Sivetz, Nicole
    Layne, Jessica
    Voss, Dillon M.
    Yang, Lucia
    Zhang, Qian
    Krainer, Adrian R.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (03)
  • [9] Reducing LDL cholesterol with exon-skipping antisense oligonucleotides
    Disterer, P.
    Simons, J. P.
    Owen, J.
    Khoo, B.
    HUMAN GENE THERAPY, 2011, 22 (10) : A31 - A32
  • [10] Effect of different dosing regimens of exon skipping antisense oligonucleotides on functional outcome in the mdx mouse model of Duchenne muscular dystrophy
    Datson, N.
    Weij, R.
    Bijl, S.
    Janson, A.
    Vermue, R.
    Testerink, J.
    van Deutekom, J.
    NEUROMUSCULAR DISORDERS, 2015, 25 : S291 - S291
12345